# Iterum Therapeutics (stock symbol: ITRM) Logo in transparent PNG format

## Iterum Therapeutics Logo large

### Iterum Therapeutics Logo large Download PNG (237.92 KB)

![Iterum Therapeutics Logo large Download PNG (237.92 KB)](/img/orig/ITRM_BIG-9bf4c604.png)

## Iterum Therapeutics Logo icon format

### Iterum Therapeutics Logo icon format Download PNG (55.35 KB)

![Iterum Therapeutics Logo icon format Download PNG (55.35 KB)](/img/orig/ITRM-8d8837e0.png)

## About Iterum Therapeutics

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

1. Website domain: iterumtx.com
2. Employees: 13
3. Marketcap: $14.89 Million USD


## Categories
- [x] ðŸ‡®ðŸ‡ª Ireland
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
